percentage of study population developing chronic experimental arthritis during a period of time
BBDR/Rhw
male
100
%
Freund's incomplete adjuvant (50 %) (between 1 and 7 days) and type II collagen (2 mg/kg) (between 1 and 7 days) then Freund's incomplete adjuvant (50 %) (between 1 and 35 days) and type II collagen (100 ug) (between 1 and 35 days)
69921
Freund's incomplete adjuvant (50 %) (between 1 and 7 days)
type II collagen (2 mg/kg) (between 1 and 7 days)
Freund's incomplete adjuvant (50 %) (between 1 and 35 days)
type II collagen (100 ug) (between 1 and 35 days)
13
percentage of study population developing chronic experimental arthritis during a period of time
BBDR/Rhw
female
100
%
Freund's incomplete adjuvant (50 %) (between 1 and 7 days) and type II collagen (2 mg/kg) (between 1 and 7 days) then Freund's incomplete adjuvant (50 %) (between 1 and 35 days) and type II collagen (100 ug) (between 1 and 35 days)
69922
Freund's incomplete adjuvant (50 %) (between 1 and 7 days)
type II collagen (2 mg/kg) (between 1 and 7 days)
Freund's incomplete adjuvant (50 %) (between 1 and 35 days)
type II collagen (100 ug) (between 1 and 35 days)
11
calculated serum anti-rat type 2 collagen autoantibody titer
BBDR/Rhw
male
30.6
Freund's incomplete adjuvant (50 %) and type II collagen (2 mg/kg)
69925
Freund's incomplete adjuvant (50 %)
type II collagen (2 mg/kg)
13
calculated serum anti-rat type 2 collagen autoantibody titer
BBDR/Rhw
female
31.7
Freund's incomplete adjuvant (50 %) and type II collagen (2 mg/kg)